SUBSCRIBE
SUBSCRIBE
News   Business

Teva Pharmaceutical Industries Limited Issues Updated Conference Call Information for First Quarter 2012 Financial Results on May 9, 2012

May 9, 2012 | 
1 min read
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today issued updated dial-in information regarding the conference call to be held today, May 9, 2012 at 8:30 a.m. ET to discuss its first quarter 2012 results.
Earnings Asia
MORE ON THIS TOPIC
Sign of divorce. Broken paper heart on blue background, top view, copy space
Business
Novo Breaks $598M Heartseed Pact Amid ‘Decisive Restructuring’ by New CEO
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Tablets. Medicinal capsules on a white background. pharmacies in the country. medicines in the state. Lots of capsules for treatment. Pharmacy network of the country.
Opinion
The Urgent Need To Redefine the Future of UK Biotech
October 1, 2025
 · 
6 min read
 · 
Kerstin Papenfuss
Company downsizing, staff reduction and layoffs. Employee dismissal, firing and unemployment. Business concept.
Layoffs
Sutro Makes Deeper Cuts To Extend Runway Into 2027, Reach Key Data Readout
September 30, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.
Series A
Novo-Backed Crystalys Debuts With $205M to Tackle Gout
September 30, 2025
 · 
2 min read
 · 
Tristan Manalac